BAVENCIO: New Drug Trials Snapshot Posted

A new  DRUG TRIALS SNAPSHOT is now available.

BAVENCIO is used to treat a rare type of skin cancer called Merkel cell carcinoma (MCC) in adults and in pediatric patients 12 years and older. It is used in patients for whom the cancer has spread (metastatic).

See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.